Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Neurogenic detrusor overactivity is associated with decreased expression and function of the large conductance voltage- and ca(2+)-activated k(+) channels.
Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis.
Progressive MS: from pathophysiology to drug discovery.
Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins.
G protein-coupled receptor kinase 2 and group I metabotropic glutamate receptors mediate inflammation-induced sensitization to excitotoxic neurodegeneration.
Potent and Selective Agonists of Sphingosine 1-Phosphate 1 (S1P1): Discovery and SAR of a Novel Isoxazole Based Series.
Neuroinflammation: Transport disruption in multiple sclerosis.
Emotional dysfunctions in neurodegenerative diseases.
Genetic factors and multiple sclerosis in the Moroccan population: A role for HLA class II.
Association study of four polymorphisms in the interleukin-7 receptor alpha gene with multiple sclerosis in Eastern Iran.
[A DTI study of the spinal cord lesion in patients with multiple sclerosis during the follow-up after relapse].
What are exosomes and how can they be used in multiple sclerosis therapy?
Clinical Feasibility of Synthetic MRI in Multiple Sclerosis: A Diagnostic and Volumetric Validation Study.
Perforin competent CD8 T cells are sufficient to cause immune-mediated blood-brain barrier disruption.
Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice.
Comparison of Intelligibility Measures for Adults with Parkinson's Disease, Multiple Sclerosis and Healthy Controls.
Sexual problems among women with multiple sclerosis.
Toward the identification of neuroprotective agents: g-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist.
SPatial REgression Analysis of Diffusion tensor imaging (SPREAD) for longitudinal progression of neurodegenerative disease in individual subjects.
Monitoring interferon β treatment response with magnetic resonance spectroscopy in relapsing remitting multiple sclerosis.
Cytokines and chemokines in multiple sclerosis.
Brainstem glioblastoma in a patient with secondary progressive multiple sclerosis.
Temporal expression of growth factors triggered by epiregulin regulates inflammation development.
Analysis of the treatment of neuromyelitis optica.
A forgotten aspect of the NICE reference case: an observational study of the health related quality of life impact on caregivers of people with multiple sclerosis.

Pages